bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.05.05.723102

Cosine Similarity Conflates Clinically Distinct Cancer Variants: A Case for Typed-Graph Retrieval in Precision Oncology Decision Support

Abstract

Retrieval-augmented generation (RAG) is increasingly applied to clinical decision support in oncology, where treatment selection depends on identifying a patients specific somatic variant from an NGS report and matching it to evidence-graded therapy options. The vector retrieval that underlies most RAG systems uses cosine similarity over text embeddings, an architecture optimized for linguistic proximity rather than entity-level identity. We hypothesize that cosine-similarity-based retrieval conflates clinically distinct cancer variants at clinically relevant rates, while a typed-graph approach in which each variant is a discrete node preserves variant-level identity by construction. We evaluated 9 cancer variant pairs with differential FDA-approved therapy indications, variant identity informed by the CIViC clinical variant evidence database and primary clinical literature. The pairs span BRAF, EGFR, KRAS, ERBB2, PIK3CA, and NTRK1, including the canonical EGFR L858R vs T790M sensitivity-versus-resistance pair and KRAS G12C vs G12D (only G12C has an FDA-approved targeted therapy). We computed pairwise cosine similarity across three open-source embedding models (PubMedBERT, MedCPT, BGE-large-en-v1.5) and three text formats, and in this revision added template-matched negative controls, formal separation metrics, variant-specific long-format text, corpus-level ranked retrieval, an exact-ID guardrail baseline, and an end-to-end typed-graph pipeline. Across the medium format (gene + variant + tumor type), 100% of clinically distinct variant pairs (9/9) had cosine similarity [≥] 0.95 under both biomedical encoders (PubMedBERT, MedCPT; exact binomial 95% CI [66.4%, 100%]); the general-purpose encoder (BGE-large-en-v1.5) conflated 11%. The biomedically pre-trained encoders performed worse, not better, than the general-purpose encoder. Template-matched but biologically unrelated negative controls scored lower than the clinically distinct pairs, confirming the high similarities are genuine conflation and not a template artifact, and equivalent-notation positives were not separable from clinically distinct pairs by a cosine threshold (medium-format ROC-AUC [≤] 0.54, below 0.5 for the biomedical encoders). In corpus-level ranked retrieval over a 52-document corpus, the wrong paired variant appeared in the top 5 for 75% to 100% of queries under the biomedical encoders. Adding an exact variant-ID guardrail to cosine retrieval, and routing retrieval through an end-to-end typed-graph pipeline, both reduced wrong-variant retrieval to zero. We argue that, conditional on a normalization layer that resolves variant strings to canonical nodes, typed-graph retrieval, or vector retrieval coupled with strict variant-ID guardrails, should be the default substrate for variant-level clinical decision support. We empirically validate the typed-graph baseline end-to-end on the same nine-pair benchmark, demonstrating 95.8% normalization accuracy and a 0% wrong-variant retrieval rate.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Khan, U. A.. 2026-05-11. Cosine Similarity Conflates Clinically Distinct Cancer Variants: A Case for Typed-Graph Retrieval in Precision Oncology Decision Support. https://doi.org/10.64898/2026.05.05.723102

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A meta-interaction basis for cell-cell communication in tissues

Tissue function depends on signals exchanged between cells and the responses they elicit. Yet whether diverse cell-cell interactions in situ form recurrent sender-receiver programs remains unclear. We present SpiderNet, an interpretable representation-learning framework that discovers such directed programs as a compact basis of cell-cell meta-interactions (MIs) from spatial transcriptomics. SpiderNet jointly learns which sender regulators, ligand-receptor pairs, and receiver targets define each MI and where each program is active across neighboring cell pairs. The resulting representation traces multicellular relays and links communication to cell states, perturbation responses, and phenotypes. SpiderNet recovers ground-truth MIs and their molecular components in simulations and, in real tissues, shows stronger direction-specific agreement with independently curated regulatory programs in senders and receivers than alternative methods. Across more than 5.8 million spatially profiled cells, SpiderNet resolves an SPP1-THBS relay linking monocytes, fibroblasts, and tumor cells within an immune-suppressive ovarian cancer niche, predicts T-cell responses to held-out melanoma-cell perturbations, and identifies a T-cell-associated brain-aging program and age-predictive signals that transfer across regions and platforms. It reveals a recurrent pan-cancer COLLAGEN-linked fibroblast-tumor program whose projected abundance in independent cohorts is associated with poorer survival and non-response to immunotherapy. SpiderNet thus establishes MIs as a reusable organizational layer between molecular interactions and tissue phenotypes, providing a framework to resolve, compare, trace, and perturb multicellular regulation in situ.

bioinformatics↗

Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction

Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale studies. In addition, existing computational approaches often struggle to effectively integrate heterogeneous biomedical data, capture the complex higher-order topological signatures of biological interactomes, and generalize to unseen entities. Here, we present HANAMI (Heterogeneous grAph coNtrastive leArning for drug-gene-disease Motif predIction), a multi-view deep graph learning framework designed to model complex interactions among drugs, genes, and diseases. HANAMI integrates diverse heterogeneous biomedical knowledge, including chemical structures, genomic sequences, and clinical phenotypes, and leverages relation-aware topology encoding, structure-aware aggregation, and contrastive learning to enable accurate motif prediction with biological context from the network. Systematic evaluation on benchmark datasets shows that HANAMI achieves up to 6% improvements over existing state-of-the-art methods in predicting drug-gene-disease motifs. The framework further demonstrates strong inductive generalization, maintaining an [~]18% performance advantage in zero-shot settings involving previously unseen entities. Beyond predictive performance, HANAMI effectively prioritizes drug-disease relationships investigated in Phase II or III trials while identifying candidate genes that suggest plausible mechanistic links. Together, HANAMI provides a computational framework for interpreting complex biomedical interactions, offering a scalable foundation to accelerate drug repurposing and therapeutic innovation.

bioinformatics↗

PTMExplorer: A Multi-Dimensional Integrative Visualization Platform for Protein Post-Translational Modification Function and Structure

Deciphering the functions of post-translational modifications (PTMs) is a critical bridge connecting large-scale modification proteomics data to mechanistic studies. However, most existing tools for visualizing PTM omics data are limited to site catalogs or single-dimensional feature displays. They lack the capability to simultaneously map user-derived differential modification sites onto multi-dimensional contexts, including protein three-dimensional (3D) structure, evolutionary conservation, functional sites, and disease associations. This limitation makes it difficult for researchers to rapidly assess the biological importance of candidate sites from among a vast number of differentially modified sites. Here, we present PTMExplorer, an interactive platform for the multi-dimensional visualization of protein PTMs. PTMExplorer comprises three core modules: PTM Inspector, built upon ProtVista, provides a multi-track, sequence-feature integrated view incorporating intrinsically disordered region (IDR) prediction (via flDPnn), surface accessibility calculation (via FreeSASA), and UniProt functional annotations; PTM 3D Locator, leveraging the Nightingale/Mol* engine, anchors modification sites onto AlphaFold/Protein Data Bank (PDB) 3D structures through residue mapping via PDBe-SIFTS; and PTM Overview, utilizing the R circlize package, presents a panoramic polar circos plot illustrating modification distribution and inter-group differential regulation. Additionally, three major disease-associated modification databases (PTMD, qPTM, and PhosCancer) are integrated as PTM-Disease Nexus, enabling co-localization comparison between user-defined differential sites and reported disease-related sites. PTMExplorer currently supports eight model organisms, accepts user-uploaded differential analysis results, and provides multi-dimensional annotations and various visualization options (https://www.bioladder.cn/PTMExplorer/). Using a multi-omics dataset from hepatocellular carcinoma (18 patients, 9 modification types) as a case study, we demonstrate the practical utility of PTMExplorer in screening potential biomarkers, revealing multi-modification coordination mechanisms, and distinguishing between absolute and relative quantification patterns.

bioinformatics↗